[Corrigendum] Preparation and biological evaluation of a novel pH-sensitive poly (β-malic acid) conjugate for antitumor drug delivery

• Authors:
  • Youbei Qiao
  • Bao Liu
  • Yifan Peng
  • Erlong Ji
  • Hong Wu

• View Affiliations

  
  Affiliations: Department of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Shiquanhe Medical Station, A'li, Tibet 859000, P.R. China
• Published online on: August 7, 2019     https://doi.org/10.3892/ijmm.2019.4308
• Pages: 1595-1595

• Copyright : © Qiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Int J Mol Med 42: [Related article:] 3495-3502, 2018; DOI: 10.3892/ijmm.2018.3893

Following the publication of the above article, the authors have realized that the chemical structure presented for the intermediate product in Fig 3 was drawn incorrectly; specfically, the 'N's had been omitted from the structure.

Figure 3 Synthesis of PMLA-Hz-DOX and PMLA-ami-DOX. PMLA, poly (β-malic acid); DOX, doxorubicin.

The structure as it should have appeared is shown in the revised version of Fig. 3 opposite. All the authors agree to the contents of this Corrigendum, and apologize to the Editor of International Journal of Molecular Medicine and to the readership for any inconvenience caused.